The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
James Benjamin Galloway, Kimme Leanne Hyrich, Louise Mercer, William Gregory Dixon, Kath D. Watson, Mark Lunt, Deborah P. M. Symmons, on behalf of the British Society for Rheumatology Biologics Register
Abstract